Neurologic complications of FK 506.

PubWeight™: 1.34‹?› | Rank: Top 10%

🔗 View Article (PMC 2964000)

Published in Transplant Proc on December 01, 1991


B H Eidelman1, K Abu-Elmagd, J Wilson, J J Fung, M Alessiani, A Jain, S Takaya, S N Todo, A Tzakis, D Van Thiel

Author Affiliations

1: Department of Neurology, University of Pittsburgh School of Medicine, PA 15261.

Articles citing this

Adverse effects of FK 506 overdosage after liver transplantation. Transplant Proc (1993) 1.18

What have we learned about primary liver transplantation under tacrolimus immunosuppression? Long-term follow-up of the first 1000 patients. Ann Surg (1999) 1.02

PRES (posterior reversible encephalopathy syndrome), a rare complication of tacrolimus therapy. Emerg Radiol (2008) 1.01

Age, model for end-stage liver disease score, and organ functioning predict posttransplant tacrolimus neurotoxicity. Liver Transpl (2008) 0.95

Recurrent reversible cerebral edema after long term immunosuppression with tacrolimus. J Neurol (2002) 0.95

Calcineurin Inhibitors Associated Posterior Reversible Encephalopathy Syndrome in Solid Organ Transplantation: Report of 2 Cases and Literature Review. Medicine (Baltimore) (2016) 0.90

Neurologic complications after liver transplantation. World J Hepatol (2013) 0.83

Recent advances in hepatic transplantation at the University of Pittsburgh. Clin Transpl (1993) 0.83

Genome-wide screening for genes associated with FK506 sensitivity in fission yeast. PLoS One (2011) 0.82

Primary adult liver transplantation under tacrolimus: more than 90 months actual follow-up survival and adverse events. Liver Transpl Surg (1999) 0.81

Tacrolimus-induced encephalopathy and polyneuropathy in a renal transplant recipient. BMJ Case Rep (2013) 0.81

Late onset tacrolimus-induced life-threatening polyneuropathy in a kidney transplant recipient patient. Clin Kidney J (2012) 0.78

Switching STudy of Kidney TRansplant PAtients with Tremor to LCP-TacrO (STRATO): an open-label, multicenter, prospective phase 3b study. Clin Transplant (2015) 0.77

Targeting Tumor Necrosis Factor Alpha for Alzheimer's Disease. Curr Alzheimer Res (2016) 0.75

Posterior reversible encephalopathy syndrome in a renal allograft recipient: A complication of immunosuppression? Indian J Nephrol (2013) 0.75

Hepatic veno-occlusive disease resulting in tacrolimus toxicity after allogeneic hematopoietic stem cell transplantation. Blood Res (2013) 0.75

Tacrolimus-induced cerebral blindness in a liver transplant patient. Indian J Ophthalmol (2016) 0.75

Acute demyelinating polyneuropathy after lung transplantation: guillain-barré syndrome or tacrolimus toxicity? Case Rep Transplant (2014) 0.75

Influence of FK 506 (tacrolimus) on circulating CD4+ T cells expressing CD25 and CD45RA antigens in 19 patients with chronic progressive multiple sclerosis participating in an open label drug safety trial. Autoimmunity (1994) 0.75

Posterior Reversible Encephalopathy Syndrome after Heart Transplantation: Diagnosis and Immunosuppressive Therapy. Tex Heart Inst J (2017) 0.75

Articles cited by this

Kidney transplantation under FK 506. JAMA (1990) 7.45

Incidence and treatment of rejection episodes in primary orthotopic liver transplantation under FK 506. Transplant Proc (1991) 2.59

Acute neurological complications after liver transplantation with particular reference to intraoperative cerebral air embolus. Ann Surg (1978) 2.48

Central nervous system toxicity after liver transplantation. The role of cyclosporine and cholesterol. N Engl J Med (1987) 1.98

Use of FK 506 in pediatric patients. Transplant Proc (1991) 1.77

Association between cyclosporin neurotoxicity and hypomagnesaemia. Lancet (1984) 1.60

Prolongation of skin allograft survival in rats by a novel immunosuppressive agent, FK506. Transplantation (1988) 1.21

Cerebral blindness and encephalopathy with cyclosporin A toxicity. Neurology (1987) 1.08

Generalised epileptic fits in renal transplant recipients given cyclosporin A. Br Med J (Clin Res Ed) (1984) 1.07

Cyclosporin-associated akinetic mutism and extrapyramidal syndrome after liver transplantation. J Neurol Neurosurg Psychiatry (1990) 1.07

Expressive dysphasia possibly related to FK506 in two liver transplant recipients. Transplantation (1990) 1.04


Effect of FK 506 and cyclosporine on heart allograft survival in rats. Transplant Proc (1991) 0.87

Spinal cord and cerebellar-like syndromes associated with the use of cyclosporine in human recipients of allogeneic marrow transplants. Transplant Proc (1985) 0.82

Cyclosporin-associated mania. Biol Psychiatry (1984) 0.82

Effect of FK 506 on heart allograft survival in highly sensitized recipient rats in comparison with cyclosporine. Transplant Proc (1991) 0.81

Articles by these authors

FK 506 for liver, kidney, and pancreas transplantation. Lancet (1989) 13.70

Cell migration and chimerism after whole-organ transplantation: the basis of graft acceptance. Hepatology (1993) 8.76

Kidney transplantation under FK 506. JAMA (1990) 7.45

The many faces of multivisceral transplantation. Surg Gynecol Obstet (1991) 6.89

Clustered mutations in HIV-1 gag are consistently required for escape from HLA-B27-restricted cytotoxic T lymphocyte responses. J Exp Med (2001) 6.51

Comparison of HIV-antibody prevalence in patients consenting to and declining HIV-antibody testing in an STD clinic. JAMA (1988) 6.14

Neurological complications of pertussis inoculation. Arch Dis Child (1974) 6.12

Abdominal organ cluster transplantation for the treatment of upper abdominal malignancies. Ann Surg (1989) 5.78

Liver, kidney, and thoracic organ transplantation under FK 506. Ann Surg (1990) 5.01

Intestinal transplantation in composite visceral grafts or alone. Ann Surg (1992) 4.96

Conversion from cyclosporine to FK 506 in liver allograft recipients with cyclosporine-related complications. Transplant Proc (1990) 4.90

Immune responses to adenovirus and adeno-associated virus in humans. Gene Ther (1999) 4.65

Liver transplantation (1). N Engl J Med (1989) 4.53

The ratio of 2nd to 4th digit length: a predictor of sperm numbers and concentrations of testosterone, luteinizing hormone and oestrogen. Hum Reprod (1998) 4.42

Murine liver allograft transplantation: tolerance and donor cell chimerism. Hepatology (1994) 4.32

Pancreatic islet transplantation after upper abdominal exenteration and liver replacement. Lancet (1990) 4.18

Baboon-to-human liver transplantation. Lancet (1993) 4.01

Histopathologic variability in usual and nonspecific interstitial pneumonias. Am J Respir Crit Care Med (2001) 4.01

Liver transplantation in the United States, 1999-2008. Am J Transplant (2010) 3.92

Replacement of donor lymphoid tissue in small-bowel transplants. Lancet (1991) 3.85

Is migraine food allergy? A double-blind controlled trial of oligoantigenic diet treatment. Lancet (1983) 3.79

Massive outbreak of Escherichia coli O157:H7 infection in schoolchildren in Sakai City, Japan, associated with consumption of white radish sprouts. Am J Epidemiol (1999) 3.75

Variable chimerism, graft-versus-host disease, and tolerance after different kinds of cell and whole organ transplantation from Lewis to brown Norway rats. Transplantation (1995) 3.63

Transplantation of multiple abdominal viscera. JAMA (1989) 3.59

Selective inhibition of human immunodeficiency viruses by racemates and enantiomers of cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine. Antimicrob Agents Chemother (1992) 3.52

A randomised controlled trial comparing two schedules of antenatal visits: the antenatal care project. BMJ (1996) 3.50

Implementation of a high-sensitivity Micro-Angiographic Fluoroscope (HS-MAF) for in-vivo endovascular image guided interventions (EIGI) and region-of-interest computed tomography (ROI-CT). Proc SPIE Int Soc Opt Eng (2008) 3.49

The use of a synthetic medium in the isolation of the somatic antigens of Bact. typhi-murium and Bact. typhosum. Biochem J (1940) 3.45

Selected topics on FK 506, with special references to rescue of extrahepatic whole organ grafts, transplantation of "forbidden organs," side effects, mechanisms, and practical pharmacokinetics. Transplant Proc (1991) 3.40

Benign intracranial hypertension following corticosteroid withdrawal in childhood. Br Med J (1970) 3.38

Orthotopic liver transplantation for patients with hepatitis B virus-related liver disease. Hepatology (1991) 3.34

Kidney transplantation under FK 506 immunosuppression. Transplant Proc (1991) 3.31

Early trials with FK 506 as primary treatment in liver transplantation. Transplant Proc (1990) 3.29

Use of OKT3 with cyclosporin and steroids for reversal of acute kidney and liver allograft rejection. Nephron (1987) 3.26

Human mucosal addressin cell adhesion molecule-1 is preferentially expressed in intestinal tract and associated lymphoid tissue. Am J Pathol (1997) 3.24

Rejection of multivisceral allografts in rats: a sequential analysis with comparison to isolated orthotopic small-bowel and liver grafts. Surgery (1990) 3.18

The effect of graft function on FK506 plasma levels, dosages, and renal function, with particular reference to the liver. Transplantation (1991) 3.14

A multifactorial system for equitable selection of cadaver kidney recipients. JAMA (1987) 3.01

Biliary tract complications in human orthotopic liver transplantation. Transplantation (1987) 2.95

Outcome analysis of 71 clinical intestinal transplantations. Ann Surg (1995) 2.95

Infection of the surgical site after arthroplasty of the hip. J Bone Joint Surg Br (2005) 2.94

Liver transplantation (2). N Engl J Med (1989) 2.93

Long-term survival after liver transplantation in 4,000 consecutive patients at a single center. Ann Surg (2000) 2.91

Equitable allocation of extrarenal organs: with special reference to the liver. Transplant Proc (1988) 2.85

Functional characterization of infiltrating T lymphocytes in human hepatic allografts. Hum Immunol (1986) 2.84

Hematolymphoid cell trafficking, microchimerism, and GVH reactions after liver, bone marrow, and heart transplantation. Transplant Proc (1993) 2.81

Effects of requiring prior authorization for selected antimicrobials: expenditures, susceptibilities, and clinical outcomes. Clin Infect Dis (1997) 2.78

Cadaveric small bowel and small bowel-liver transplantation in humans. Transplantation (1992) 2.75

Growth in the use of antibiotics in the community in England and Scotland in 1980-93. BMJ (1996) 2.74

The association of Epstein-Barr virus with smooth-muscle tumors occurring after organ transplantation. N Engl J Med (1995) 2.68

Clearing the cataract backlog. Br J Ophthalmol (1987) 2.66

Management of intestinal transplantation in humans. Transplant Proc (1992) 2.62

Effect of hepatic dysfunction and T tube clamping on FK 506 pharmacokinetics and trough concentrations. Transplant Proc (1990) 2.60

Suppression of allograft rejection with FK506. I. Prolonged cardiac and liver survival in rats following short-course therapy. Transplantation (1990) 2.59

Incidence and treatment of rejection episodes in primary orthotopic liver transplantation under FK 506. Transplant Proc (1991) 2.59

The prediction of risk of recurrence and time to recurrence of hepatocellular carcinoma after orthotopic liver transplantation: a pilot study. Hepatology (1997) 2.57

Risk factors for surgical site infection following caesarean section in England: results from a multicentre cohort study. BJOG (2012) 2.57

Adverse impact of surgical site infections in English hospitals. J Hosp Infect (2005) 2.51

FK506 "rescue" for resistant rejection of renal allografts under primary cyclosporine immunosuppression. Transplantation (1994) 2.50

Pregnancy after liver transplantation under tacrolimus. Transplantation (1997) 2.50

A randomized trial of primary liver transplantation under immunosuppression with FK 506 vs cyclosporine. Transplant Proc (1991) 2.49

Pharmacokinetics of FK 506: preclinical and clinical studies. Transplant Proc (1990) 2.48

Leber's hereditary optic atrophy: a possible defect of cyanide metabolism. Clin Sci (1965) 2.44

IgA deficiency, epilepsy, and phenytoin treatment. Lancet (1975) 2.40

Maternal feeding practices and beliefs and their relationships to overweight in early childhood. J Dev Behav Pediatr (2001) 2.39